Overview
Acute rheumatic fever is an autoimmune response to a previous group A beta-hemolytic Streptococcus infection causing acute generalized anti-inflammatory response primarily affecting the heart. It also affects the joints, brain and skin.
Initial episode or symptoms usually occurs 2-4 weeks after group A beta-hemolytic Streptococcus infection.
Patients presenting with acute rheumatic fever are severely unwell, in extreme pain and requires hospitalization.
Goals of therapy includes providing education for patient and patient’s caregivers, eradicating group A beta-hemolytic Streptococcus and symptomatic relief of acute manifestations of acute rheumatic fever.
For further information regarding the management of Acute Rheumatic Fever, please refer to Disease Algorithm for the Treatment Guideline.
Initial episode or symptoms usually occurs 2-4 weeks after group A beta-hemolytic Streptococcus infection.
Patients presenting with acute rheumatic fever are severely unwell, in extreme pain and requires hospitalization.
Goals of therapy includes providing education for patient and patient’s caregivers, eradicating group A beta-hemolytic Streptococcus and symptomatic relief of acute manifestations of acute rheumatic fever.
For further information regarding the management of Acute Rheumatic Fever, please refer to Disease Algorithm for the Treatment Guideline.